The 95th Hospital Of Putian，putian, Fujian, China
Clinical trials sponsored by The 95th Hospital Of Putian，putian, Fujian, China, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a common supplement shrink fatty liver in a rare diabetes? Results expected Sep 2027 (estimated)
-
Can a diabetes drug combo revive the Body's growth hormone axis and protect the liver?
Disease control Not yet recruitingThis trial is testing whether adding dapagliflozin to metformin can improve levels of a growth-related hormone (IGF-1) in men with type 2 diabetes and fatty liver disease. The study will include 84 men aged 30-60 who are already taking metformin. Half will continue metformin alon…
Sponsor: The 95th Hospital of Putian，Putian, Fujian, China • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Rowing and cycling: a new exercise combo to fight diabetes inflammation?
Disease control Not yet recruitingThis trial tests whether different combinations of rowing and cycling exercise can reduce inflammation and improve blood sugar control in people newly diagnosed with type 2 diabetes. Participants, aged 18-60 and not yet on medication, will be assigned to one of five exercise prog…
Sponsor: The 95th Hospital of Putian，Putian, Fujian, China • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a common supplement shrink fatty liver in a rare diabetes?
Disease control Not yet recruitingThis trial tests whether taking coenzyme Q10 (CoQ10) for 12 weeks can reduce fat buildup in the liver of people with mitochondrial diabetes, a rare form of diabetes caused by mitochondrial dysfunction. Participants with the m.3243A>G mutation will take 300 mg of CoQ10 daily, and …
Sponsor: The 95th Hospital of Putian，Putian, Fujian, China • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC